TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12037720

Group type: EXPERIMENTAL
Intervention: Vitamin A (retinol) at a dose of 50,000 IU/d for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL) for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg T(3) after 10 days of PL treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg T(3) after 10 days of vitamin A treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL) for 10 days in elderly subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A for 10 days in elderly subjects
Number of subjects: 0
Study: 10404854

Group type: EXPERIMENTAL
Intervention: Acebutolol 200 mg once daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg once daily
Number of subjects: 40
Study: 7672750

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sleep Phase Advancement
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Polysomnographic study
Number of subjects: 27
Study: 2184330

Group type: EXPERIMENTAL
Intervention: Oral immunization with killed Haemophilus influenzae
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study: 7023086

Group type: EXPERIMENTAL
Intervention: Intrathecal and peridural injection of 0.5 ml (= 10 mg) Triamcinolone hexacetonide
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 35
Study: 31525420

Group type: COMPARATOR
Intervention: Pictorial fruit nudge (grape image) on plate
Number of subjects: 122

Group type: COMPARATOR
Intervention: Large portion pictorial nudge (large portion carrot image)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Small portion pictorial nudge (small portion carrot image)
Number of subjects: 122
Study: 31450986

Group type: EXPERIMENTAL
Intervention: Crystalloid-based prime solution
Number of subjects: 21

Group type: COMPARATOR
Intervention: Erythrocyte-based prime solution (control)
Number of subjects: 21
Study: 28079534

Group type: EXPERIMENTAL
Intervention: Olmesartan 20mg once daily for 16 weeks
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Azilsartan 20mg once daily for 16 weeks
Number of subjects: 84
Study: 24197518

Group type: EXPERIMENTAL
Intervention: Red LED therapy (630 ± 10 nm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Infrared LED therapy (850 ± 10 nm)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Infrared laser therapy (780 nm) - Positive control group
Number of subjects: 30
Study: 24192067

Group type: EXPERIMENTAL
Intervention: Error-based learning (EBL)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Errorless learning (ELL)
Number of subjects: 135
Study: 21334229

Group type: EXPERIMENTAL
Intervention: Image-guided puncture technique (IGPT)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional puncture technique (CPT)
Number of subjects: 178
Study: 19605885

Group type: EXPERIMENTAL
Intervention: Decision aid delivered by clinician during office visit
Number of subjects: 98

Group type: COMPARATOR
Intervention: Pamphlet about cholesterol
Number of subjects: 98
Study: 16567610

Group type: EXPERIMENTAL
Intervention: BGMOM intervention (BGM+)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Attention control (BG meter only [MT])
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 199
Study: 12669392

Group type: EXPERIMENTAL
Intervention: Radiation therapy for malignant gliomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy for low-grade gliomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy for medulloblastoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy for germinoma and primary CNS lymphoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IMRT (Intensity-Modulated Radiation Therapy)
Number of subjects: 0
Study: 11059542

Group type: EXPERIMENTAL
Intervention: Bathing 2-5 minutes after birth
Number of subjects: 187

Group type: COMPARATOR
Intervention: Dry care (control)
Number of subjects: 187
Study: 9296277

Group type: EXPERIMENTAL
Intervention: Innogem 300 mg capsule
Number of subjects: 19

Group type: COMPARATOR
Intervention: Reference preparation
Number of subjects: 19
Study: 8345499

Group type: EXPERIMENTAL
Intervention: 240 mg verapamil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20 mg nitrendipine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination therapy (10 mg nitrendipine plus 120 mg verapamil)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single drug therapy (240 mg verapamil or 20 mg nitrendipine)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 40
Study: 3027839

Group type: EXPERIMENTAL
Intervention: 200 mg of itraconazole per day for seven days
Number of subjects: 28

Group type: COMPARATOR
Intervention: 200 mg of itraconazole per day for five days
Number of subjects: 28
Study: 29271795

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (physical exercise and psychoeducational consultations)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210
Study: 27398874

Group type: EXPERIMENTAL
Intervention: Multicomponent QI strategy
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1146
Study: 24752908

Group type: EXPERIMENTAL
Intervention: AMG 416
Number of subjects: 0
Study: 24131877

Group type: EXPERIMENTAL
Intervention: Cumulative social risk score (based on maternal reports of intimate partner violence, food insecurity, housing insecurity, maternal depressive symptoms, maternal substance use, father's incarceration)
Number of subjects: 1589

Group type: EXPERIMENTAL
Intervention: Externalizing behavioral problems (measured with the Child Behavior Checklist)
Number of subjects: 1589

Group type: EXPERIMENTAL
Intervention: Short sleep duration
Number of subjects: 1589

Group type: EXPERIMENTAL
Intervention: Watching more than 2 hours of television per day
Number of subjects: 1589
Study: 20299990

Group type: EXPERIMENTAL
Intervention: Closed-loop anaesthesia delivery system (CLADS) with continuous infusion of propofol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Manual administration of propofol adjusted by clinician
Number of subjects: 41
Study: 18619256

Group type: EXPERIMENTAL
Intervention: Zhi‐Xin‐Fang combined with standard western medicines
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard western medical therapy
Number of subjects: 62
Study: 15150183

Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g once a day
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam 3.375 g every 6 h
Number of subjects: 1558
Study: 11440287

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ezetimibe 20 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ezetimibe (both doses)
Number of subjects: 90
Study: 9772043

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 24

Group type: COMPARATOR
Intervention: 6-methylprednisolone (prednisolone)
Number of subjects: 24
Study: 7828692

Group type: EXPERIMENTAL
Intervention: Inhaled frusemide (40 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled lysine acetylsalicylate (modified protocol)
Number of subjects: 8
Study: 3136331

Group type: EXPERIMENTAL
Intervention: sorbinil (250 mg per day)
Number of subjects: 16
Study: 31352458

Group type: EXPERIMENTAL
Intervention: Air tamponade
Number of subjects: 72

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification
Number of subjects: 72
Study: 31703468

Group type: EXPERIMENTAL
Intervention: HYP (hypertrophic loading): five times 10 repetitions at 70% of 1RM with 2 minutes inter-set rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MAX (maximum strength loading): 15 times one repetition at 100% of 1RM with 3 minutes inter-set rest
Number of subjects: 10
Study: 28329181

Group type: EXPERIMENTAL
Intervention: Gatifloxacin
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Cefixime
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Ofloxacin
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 2092
Study: 25465941

Group type: EXPERIMENTAL
Intervention: Red Bull
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Red Bull + Mental Stress
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water + Mental Stress
Number of subjects: 20
Study: 23054350

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Ecologically‐Based Family Therapy (EBFT)
Number of subjects: 179
Study: 21952349

Group type: EXPERIMENTAL
Intervention: Remote postischemic conditioning (three 5-min cycles of ischemia by inflation of a cuff on the non-dominant arm to 200 mm Hg)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo (uninflated cuff)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Remote postischemic conditioning
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 18829444

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (0.625 mg/d)
Number of subjects: 10739

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10739
Study: 16495069

Group type: EXPERIMENTAL
Intervention: Single drain (group A)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Two drains (group B)
Number of subjects: 119
Study: 12908663

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atypical antipsychotics (2000 estimates)
Number of subjects: 0
Study: 11205461

Group type: EXPERIMENTAL
Intervention: Five years of adjuvant tamoxifen
Number of subjects: 577

Group type: COMPARATOR
Intervention: Two years of adjuvant tamoxifen
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Five years of tamoxifen for erbB2-negative patients
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Five years of tamoxifen for erbB2-positive patients
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Five years of tamoxifen for ER-positive patients
Number of subjects: 577
Study: 9093633

Group type: EXPERIMENTAL
Intervention: D-P (dapsone-pyrimethamine)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 8245996

Group type: EXPERIMENTAL
Intervention: Subvastus arthrotomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Paramedian arthrotomy
Number of subjects: 20
Study: 2880755

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g every 8th hour for 24 hours followed by cefadroxil 0.5 g twice daily for 6 days
Number of subjects: 2

Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Cefuroxime and cefadroxil (treatment)
Number of subjects: 2
Study: 30801523

Group type: EXPERIMENTAL
Intervention: Heterologous Human Adult Liver‐derived Progenitor Cells (HepaStem)
Number of subjects: 20
Study: 30248126

Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Dietary diversity
Number of subjects: 714
Study: 27428596

Group type: EXPERIMENTAL
Intervention: Standing on a 65cm elevated platform
Number of subjects: 0

Group type: COMPARATOR
Intervention: Floor level standing
Number of subjects: 0
Study: 24405007

Group type: EXPERIMENTAL
Intervention: Behavioral treatment intervention using a handheld, vibrating stimulation device
Number of subjects: 11

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 11
Study: 22968527

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g over 10 minutes followed by 1 g over eight hours)
Number of subjects: 13273

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 13273
Study: 19882541

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Scanning laser polarimetry (GDx)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Visual evoked potentials (VEP)
Number of subjects: 81
Study: 17563186

Group type: EXPERIMENTAL
Intervention: Happy mood (induced by viewing happy movie clips)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad mood (induced by viewing sad movie clips)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral mood (induced by viewing neutral movie clips)
Number of subjects: 0
Study: 15264116

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg/day for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 46
Study: 12271297

Group type: EXPERIMENTAL
Intervention: AE-941 at 240 mL/d
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AE-941 at 120 mL/d
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AE-941 at 60 mL/d
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AE-941 at 30 mL/d
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AE-941 (all doses)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nonserious drug-related adverse events
Number of subjects: 49
Study: 9824882

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients on visual continuous performance test (CPT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal controls on visual continuous performance test (CPT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Adults with developmental attentional/learning disorders on visual continuous performance test (CPT)
Number of subjects: 48
Study: 7911530

Group type: EXPERIMENTAL
Intervention: Celiprolol (0.15 mg/kg, intravenous)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol (intravenous)
Number of subjects: 30
Study: 2594919

Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30965344

Group type: EXPERIMENTAL
Intervention: Dexamethasone 25 mg/m2 daily for 4 days, repeated every 28 days over 32 weeks (first trial)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dexamethasone 50 mg/m2 every 4 weeks for 12 weeks, followed by 25 mg/m2 every 4 weeks for 36 weeks (second trial)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined analysis of both trials
Number of subjects: 22
Study: 28235859

Group type: EXPERIMENTAL
Intervention: 12° head-down tilt (HDT) with ambient air for 29 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12° head-down tilt (HDT) with 0.5% CO2 for 29 hours
Number of subjects: 0
Study: 26358516

Group type: EXPERIMENTAL
Intervention: Intubating-laryngeal mask airway (I-LMA)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 29
Study: 23364890

Group type: EXPERIMENTAL
Intervention: K3 prosthetic foot
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gait training
Number of subjects: 10

Group type: COMPARATOR
Intervention: K1/K2 prosthetic feet
Number of subjects: 10
Study: 21638048

Group type: EXPERIMENTAL
Intervention: Toremifene (TOR) 40 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anastrozole (ANA) 1 mg daily
Number of subjects: 0
Study: 18684571

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard methadone treatment
Number of subjects: 123
Study: 16722959

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention for weaning patients from mechanical ventilation
Number of subjects: 0
Study: 14518142

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei and Lactobacillus acidophilus (10(10)-10(12) CFU/g)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (10(10)-10(12) CFU/g)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (pasteurized cow milk)
Number of subjects: 89
Study: 16881093

Group type: EXPERIMENTAL
Intervention: Arthroscopic synovectomy (AS) followed by intraarticular corticosteroid (IAC) treatment
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Arthroscopic synovectomy (AS)
Number of subjects: 22
Study: 10677890

Group type: EXPERIMENTAL
Intervention: Nebulized anaesthetics (10 ml of 1% trimecain)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isotonic chlorine solution
Number of subjects: 80
Study: 8735490

Group type: EXPERIMENTAL
Intervention: Blocked radiotherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 90
Study: 1837260

Group type: EXPERIMENTAL
Intervention: 200 mg etodolac twice daily for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 mg piroxicam once daily for 12 weeks
Number of subjects: 60
Study: 7060822

Group type: EXPERIMENTAL
Intervention: 2% miconazole nitrate aerosol spray powder
Number of subjects: 46

Group type: COMPARATOR
Intervention: 1% tolnaftate aerosol spray powder
Number of subjects: 46
Study: 28927706

Group type: EXPERIMENTAL
Intervention: Evolocumab (140 mg every 2 weeks or 420 mg once per month)
Number of subjects: 27564
Study: 25562510

Group type: EXPERIMENTAL
Intervention: Functional incidental training (FIT) program consisting of 4 extra episodes of functional exercise daily during SSR
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Functional incidental training (FIT) program
Number of subjects: 60
Study: 24673819

Group type: EXPERIMENTAL
Intervention: Intravenous silibinin (20 mg/kg daily for 14 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 20
Study: 22472267

Group type: EXPERIMENTAL
Intervention: Low intensity exercise (LIE) - exercise at 10% below ventilatory threshold (VT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High intensity exercise (HIE) - exercise at 10% above VT
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control - seated for 30 min
Number of subjects: 8
Study: 19233016

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 78
Study: 17071000

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for chronic pain, specific details on dosage and duration not available.
Number of subjects: 0
Study: 15351240

Group type: EXPERIMENTAL
Intervention: Microvessel density evaluation using immunohistochemical localization of vWF, cytokeratin 34BE-12, and HSPG.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Microvessel density evaluation within 2 standard deviations (SD) of the mean.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cytokeratin and HSPG localization patterns.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Evaluation of HGPIN for microvessel density by localization of vWF.
Number of subjects: 50
Study: 11588683

Group type: EXPERIMENTAL
Intervention: Group 1 (123 ml of 300 mgl/ml)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 2 (112 ml of 335 mgl/ml)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 3 (100 ml of 370 mgl/ml)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (lower iodine concentrations)
Number of subjects: 75
Study: 9540151

Group type: EXPERIMENTAL
Intervention: 30 mg/kg propacetamol
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.2 mg/kg morphine
Number of subjects: 80
Study: 8022626

Group type: EXPERIMENTAL
Intervention: Combination of low-dose morphine (2 mg) and bupivacaine (25 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bupivacaine (25 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Morphine (2 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: All treatments (Combination, Bupivacaine, Morphine)
Number of subjects: 13
Study: 2645916

Group type: EXPERIMENTAL
Intervention: Glucose (1 mg/kg po)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water alone (Control)
Number of subjects: 8
Study: 30882242

Group type: EXPERIMENTAL
Intervention: Pro II (a capsule containing 3 strains, 109 cfu per strain)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pro I (a capsule containing 3 strains, 109 cfu per strain)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29096627

Group type: EXPERIMENTAL
Intervention: Revefenacin 88 μg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Revefenacin 175 μg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Revefenacin 350 μg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Revefenacin ≥88 μg
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 26414564

Group type: EXPERIMENTAL
Intervention: Simulated day shifts (circadian alignment)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Simulated night shifts (circadian misalignment)
Number of subjects: 13
Study: 24076063

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21242072

Group type: EXPERIMENTAL
Intervention: C. laevigata (400 mg three times a day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 20205984

Group type: EXPERIMENTAL
Intervention: 40 mg isoflavones
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 60 mg isoflavones
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 80 mg isoflavones
Number of subjects: 45

Group type: COMPARATOR
Intervention: No supplement (control)
Number of subjects: 45
Study: 17919059

Group type: EXPERIMENTAL
Intervention: Air abrasion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mechanical brushing
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bur treatment (Intensive bur FG 40D4)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Admira seal (Voco)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delton FS+ (Dentsply)
Number of subjects: 60
Study: 16298723

Group type: EXPERIMENTAL
Intervention: Motivationally enhanced phone counseling (MEC)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 275
Study: 11862352

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10202368

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2% eye drops
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sodium cromoglycate 2% eye drops
Number of subjects: 34